To know the effect of Haritakyadi Churna in joint disorder patient.

A clinical study of Haritakyadi Churna with special reference to ??? ??? ? ????? ???? in management of Amavata. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/064550

Enrollment

Registered

2024-03-20

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Clinical feature of disease according to modern and Ayurveda. Fulfilling the criteria for diagnosis of rheumatoid arthritis approved by Disease activity score 28 and ACR EULAR2010. Chronicity of disease not more than 3 years. Patients willing to participate in the above trial and given informed consent.

Exclusion criteria

Exclusion criteria: Patients suffering from any other acute disease/any infectious disease /chronic disease. Patients having severe deformities. Severe ankylosed joints and Ankylosing Spondylitis. Rheumatic Arthritis, Septic Arthritis, Osteoarthritis and Gouty Arthritis. Rheumatoid Arthritis associated with other systemic disorder.

Design outcomes

Primary

Measure	Time frame
Relief in sign and symptoms of the disease. The main sign and symptoms in the study are as follows Disease activity score 28 (DAS28)Timepoint: Relief in sign and symptoms of the disease. The main sign and symptoms in the study are as follows Disease activity score 28 (DAS28)	—

Secondary

Measure	Time frame
Routine assessment of ACR EULAR2010Timepoint: 45 days study with follow up at 15 days	—

Countries

India

Contacts

Public ContactDr Sudama Singh Yadav

IMS BHU

coolpriyapps.2011@gmail.com9919008300

Outcome results